Physician

Shajadi Patan, M.D.

According to 2025 Medicare claims, Shajadi Patan, M.D. (NPI: 1073921169) practices hematology/oncology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 64132-9998. Patan is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Patan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 132 traditional Medicare patients, billed 168 HCPCS/CPT codes, and received $9,528 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 260 prescription claims across 78 beneficiaries totaling $249,951 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). Open Payments data shows 30 records totaling $715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $87,105 to $9,528. In contrast, Part D prescription costs have risen steadily, from $18,881 to $249,951. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$708K$1.4M2020 Medicare payment: $87,105 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $975,270 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,415,411 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $48,410 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $9,528 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202010915,379$87,105
202127394,262$975,270
2022294139,440$1,415,411
2023271684$48,410
2024132168$9,528

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$663K$1.3M2015 Drug cost: $18,881 (USD; Tot_Drug_Cst)2016 Drug cost: $33,308 (USD; Tot_Drug_Cst)2017 Drug cost: $125,898 (USD; Tot_Drug_Cst)2018 Drug cost: $189,736 (USD; Tot_Drug_Cst)2019 Drug cost: $171,270 (USD; Tot_Drug_Cst)2020 Drug cost: $83,757 (USD; Tot_Drug_Cst)2021 Drug cost: $775,585 (USD; Tot_Drug_Cst)2022 Drug cost: $1,325,175 (USD; Tot_Drug_Cst)2023 Drug cost: $902,199 (USD; Tot_Drug_Cst)2024 Drug cost: $249,951 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201551419$18,881
201660645$33,308
2017124568$125,898
2018143404$189,736
2019121275$171,270
202093285$83,757
2021110629$775,585
2022135792$1,325,175
2023133513$902,199
202478260$249,951

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7892$55
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3232$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Abiraterone AcetateAbiraterone Acetate18540$54,837
XareltoRivaroxaban12480$8,905
EliquisApixaban13450$8,676
AnastrozoleAnastrozole261,860$667
LetrozoleLetrozole482,160$506

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$715Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shajadi Patan, M.D.?

Tedicare shows public-source Medicare data for Shajadi Patan, M.D. (NPI 1073921169), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shajadi Patan, M.D. have ACO affiliation data?

Shajadi Patan, M.D. is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304).

What billing organization is linked to Shajadi Patan, M.D.?

Shajadi Patan, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Shajadi Patan, M.D. have Open Payments data?

Shajadi Patan, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.